ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MEI Announces FDA Clearance of IND Application for Voruciclib
americanpharmaceuticalreview
January 09, 2018MEI Pharma announced the FDA has cleared the company's Investigational New Drug Application for voruciclib, an orally available Cyclin Dependent Kinase 9 (CDK9) inhibitor, for patients with relapsed/refractory B-cell malignancies.
Pharma Sources Insight July 2025
